We must continue to protect life-saving medical and scientific research. An immediate implication of the proposed NIH cap on indirect costs "might include suspending clinical trials, so people receiving some sort of intervention in the clinical trial may not have access," said my colleague Elena Fuentes-Afflick, MD, MPH, the AAMC's Chief Science Officer. https://www.politico.com/newsletters/prescription-pulse/2025/02/11/nih-research-grant-cuts-hit-with-partial-court-pause-00203431
------------------------------
David Skorton
President and CEO
Association of American Medical Colleges
------------------------------